Nasdaq

FDA Okays Bio-Rad D-100 for HbA1c (Diabetes) Testing

Medical products manufacturer Bio-Rad Laboratories, Inc.BIO recently announced that the U.S. FDA has approved its latest D-100 System for HbA1c testing - a common blood test used to diagnose the ...
Nasdaq

Bio-Rad Receives U.S. FDA Clearance for the IH-500, Expanding Its Offering for the Blood ...

The IH-500 system was designed for small- to medium-size laboratories, offering automated blood typing and screening based on gel card technology with minimal user intervention. The system can process ...
The Scientist

Bio-Rad’s CFX Opus Deepwell Dx Real-Time PCR System Advances

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, ...
Yahoo Finance

Bio-Rad Laboratories, Inc. (BIO) Launches New Instruments, Boosts Molecular Testing Reach

In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Bio-Rad Laboratories, Inc. stands amongst them. Bio-Rad Laboratories, Inc. (NYSE:BIO), a global ...